S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled

Veradigm Stock Price, News & Analysis (NASDAQ:MDRX)

$11.48
-0.22 (-1.88%)
(As of 11/30/2023 ET)
Compare
Today's Range
$11.42
$11.84
50-Day Range
$11.48
$13.89
52-Week Range
$11.30
$19.77
Volume
1.04 million shs
Average Volume
993,649 shs
Market Capitalization
$1.25 billion
P/E Ratio
26.70
Dividend Yield
N/A
Price Target
$18.50

Veradigm MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
61.1% Upside
$18.50 Price Target
Short Interest
Bearish
10.47% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.62
Upright™ Environmental Score
News Sentiment
0.41mentions of Veradigm in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.45%
From $0.67 to $0.74 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

550th out of 949 stocks

Health Information Services Industry

2nd out of 4 stocks


MDRX stock logo

About Veradigm Stock (NASDAQ:MDRX)

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

MDRX Stock Price History

MDRX Stock News Headlines

Veradigm (MDRX) Faces Lawsuit for Inflating Revenues- Hagens Berman
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Veradigm Inc
Returns At Veradigm (NASDAQ:MDRX) Are On The Way Up
See More Headlines
Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
11/30/2023
Next Earnings (Estimated)
11/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:MDRX
CUSIP
01988P10
Employees
8,000
Year Founded
1986

Price Target and Rating

Average Stock Price Target
$18.50
High Stock Price Target
$26.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+61.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.50 billion
Cash Flow
$2.65 per share
Book Value
$11.49 per share

Miscellaneous

Free Float
106,758,000
Market Cap
$1.25 billion
Optionable
Optionable
Beta
0.87

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Richard J. PoultonMr. Richard J. Poulton (Age 58)
    CEO & Director
    Comp: $2.45M
  • Ms. Tejal Vakharia (Age 49)
    Senior VP of Marketing & Government Affairs, General Counsel and Chief Compliance Counsel
    Comp: $1.04M
  • Mr. Thomas J. Langan (Age 57)
    President & CCO
  • Ms. Leah Jones (Age 50)
    Chief Financial Officer
  • Jenny Gelinas
    Vice President of Investor Relations
  • Mr. Richard Elmore
    Senior Vice President of Corporate Development & Strategy
  • Ms. Lisa Hammond C.P.C. (Age 50)
    Senior VP & Chief Human Resources Officer
  • Mr. John Sage
    Senior Vice President of U.S. Hospitals & Health Systems Sales
  • Mr. Elliot Bryant
    Senior VP & General Manager for Classic Client Solutions Business Unit
  • Mr. John Mayr
    Senior Vice President of Global Client Delivery Organization














MDRX Stock Analysis - Frequently Asked Questions

Should I buy or sell Veradigm stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Veradigm in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View MDRX analyst ratings
or view top-rated stocks.

What is Veradigm's stock price target for 2024?

3 equities research analysts have issued 12 month price targets for Veradigm's shares. Their MDRX share price targets range from $13.00 to $26.00. On average, they expect the company's share price to reach $18.50 in the next twelve months. This suggests a possible upside of 61.1% from the stock's current price.
View analysts price targets for MDRX
or view top-rated stocks among Wall Street analysts.

How have MDRX shares performed in 2023?

Veradigm's stock was trading at $17.64 at the beginning of 2023. Since then, MDRX stock has decreased by 34.9% and is now trading at $11.48.
View the best growth stocks for 2023 here
.

When is Veradigm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 30th 2023.
View our MDRX earnings forecast
.

How were Veradigm's earnings last quarter?

Veradigm Inc. (NASDAQ:MDRX) released its quarterly earnings results on Thursday, November, 4th. The software maker reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.09. The software maker earned $369 million during the quarter, compared to analyst estimates of $376.09 million. Veradigm's revenue was down 8.2% on a year-over-year basis. During the same quarter last year, the company posted $0.15 EPS.

What ETFs hold Veradigm's stock?
What guidance has Veradigm issued on next quarter's earnings?

Veradigm issued an update on its FY 2023 earnings guidance on Monday, September, 18th. The company provided earnings per share (EPS) guidance of $0.80-$0.90 for the period, compared to the consensus EPS estimate of $0.87. The company issued revenue guidance of $615.00 million-$635.00 million, compared to the consensus revenue estimate of $638.08 million.

What is Paul Black's approval rating as Veradigm's CEO?

796 employees have rated Veradigm Chief Executive Officer Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Veradigm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Veradigm investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

Who are Veradigm's major shareholders?

Veradigm's stock is owned by many different retail and institutional investors. Top institutional shareholders include William Blair Investment Management LLC (4.00%), Fuller & Thaler Asset Management Inc. (2.33%), Westfield Capital Management Co. LP (2.20%), Charles Schwab Investment Management Inc. (1.75%), Northern Trust Corp (1.52%) and Jacobs Levy Equity Management Inc. (1.31%). Insiders that own company stock include David B Stevens, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Leah Jones, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton, Tejal Vakharia and Thomas Langan.
View institutional ownership trends
.

How do I buy shares of Veradigm?

Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Veradigm have any subsidiaries?
The following companies are subsidiares of Veradigm: HealthGrid, Practice Fusion, and ZappRx.
Read More
This page (NASDAQ:MDRX) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -